The last estimated annual incidence of worldwide exceeds that of chlamydia and gonorrhea combined. This critical review updates the state of the art on advances in diagnostics and strategies for treatment and prevention of trichomoniasis. In particular, new data on treatment outcomes for topical administration of formulations are reviewed and discussed.